Vaccine Contract Manufacturing Market Share

Statistics for the 2023 & 2024 Vaccine Contract Manufacturing market share, created by Mordor Intelligence™ Industry Reports. Vaccine Contract Manufacturing share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Vaccine Contract Manufacturing Industry

The vaccine contract manufacturing market is fragmented and competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some companies which are currently dominating the market are Ajinomoto Bio-Pharma Services, Curia Global, Catalent, Charles River Laboratories International Inc., Emergent BioSolutions Inc., CJ CheilJedang Corporation (Batavia Biosciences), Gedeon Richter (Richter-Helm BioLogics, Fujifilm Holdings Corporation, ICON PLC, IDT Biologika GmbH, Lonza Group AG, and Recipharm AB, among others.

Vaccine Contract Manufacturing Market Leaders

  1. Ajinomoto Bio-Pharma Services

  2. Curia Global

  3. Charles River Laboratories International Inc.

  4. Emergent BioSolutions Inc.

  5. IDT Biologika GmbH

*Disclaimer: Major Players sorted in no particular order

Vaccine Contract Manufacturing Market Concentration

Vaccine Contract Manufacturing Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)